Superselective intra-arterial chemoradiotherapy with docetaxel–nedaplatin for advanced oral cancer

This publication has 16 references indexed in Scilit:

• Superselective docetaxel–nedaplatin combined infusion concurrent with radiation therapy in advanced oral cancers
  Oral Oncology Extra, 2004
• Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
  Anti-Cancer Drugs, 2004
• Efficacy of Intra-arterial Infusion Therapy Using a Combination of Cisplatin and Docetaxel for Recurrent Head and Neck Cancers Compared with Cisplatin Alone
  Clinical Oncology, 2003
• Chemoembolization in the Management of Liver Tumors
  The Oncologist, 2003
• Concurrent chemoradiotherapy with new platinum compound nedaplatin in oral cancer
  Oral Oncology, 2003
• Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients
  Head & Neck, 2000
• Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck
  Journal of Clinical Oncology, 1999
• Efficacy of Targeted Chemoradiation and Planned Selective Neck Dissection to Control Bulky Nodal Disease in Advanced Head and Neck Cancer
  JAMA Otolaryngology–Head & Neck Surgery, 1999
• New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion
  Oral Oncology, 1998
• Rapid superselective high‐dose cisplatin infusion for advanced head and neck malignancies
  Head & Neck, 1992